GOAL-REPRESENTATION AND ACTION CONTROL IN PATIENTS WITH SCHIZOPHRENIA AND PREDOMINANT NEGATIVE SYMPTOMS

被引：0
|
作者：
Fritzsche, Anja [1 ]
Lincoln, Tania [1 ]
机构：
[1] Univ Hamburg Hamburg, Hamburg, Germany
来源：
SCHIZOPHRENIA RESEARCH | 2012年 / 136卷
关键词：
D O I：
10.1016/S0920-9964(12)70464-4
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
150
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [11] Impairments of event-related magnetic fields in schizophrenia patients with predominant negative symptoms
    Yefet, Keren
    Goldstein, Abraham
    Rabany, Liron
    Levkovitz, Yechiel
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2015, 231 (03) : 325 - 332
  • [12] Efficacy of paliperidone extended-release tablets in patients with schizophrenia and predominant negative symptoms
    Dirks, B.
    Eerdekens, M.
    Turkoz, I.
    Alberio, R.
    Gharabawi, G.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S162 - S162
  • [13] Paliperidone extended-release in acutely ill schizophrenia patients with and without predominant negative symptoms
    Dirks, Bryan
    Bossie, Cyndi
    Turkoz, Ibrahim
    Eederkens, Marielle
    Sherr, Jay
    Mahmoud, Ramy
    Canuso, Carla
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 82S - 82S
  • [14] Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
    Demyttenaere, Koen
    Anthonis, Elizabeth
    Acsai, Karoly
    Correll, Christoph U.
    [J]. FRONTIERS IN PSYCHIATRY, 2022, 13
  • [15] Reduced sense of agency in chronic schizophrenia with predominant. negative symptoms
    Maeda, Takaki
    Takahata, Keisuke
    Muramatsu, Taro
    Okimura, Tsukasa
    Koreki, Akihiro
    Iwashita, Satoru
    Mimura, Masaru
    Kato, Motoichiro
    [J]. PSYCHIATRY RESEARCH, 2013, 209 (03) : 386 - 392
  • [16] Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains
    Laszlovszky, I.
    Barabassy, A.
    Szatmari, B.
    Harsanyi, J.
    Szalai, E.
    Nemeth, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S902 - S903
  • [17] Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms
    Stauffer, Virginia L.
    Song, Guochen
    Kinon, Bruce J.
    Ascher-Svanum, Haya
    Chen, Lei
    Feldman, Peter D.
    Conley, Robert R.
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 195 - 201
  • [18] Folic Acid and Vitamin B12 Supplementation on Male Patients with Schizophrenia Predominant Negative Symptoms
    Simamora, Rona Hanani
    Loebis, Bahagia
    Husada, Muhammad Surya
    Effendy, Elmeida
    [J]. CURRENT NUTRITION & FOOD SCIENCE, 2020, 16 (01) : 98 - 104
  • [19] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Marc Krause
    Yikang Zhu
    Maximilian Huhn
    Johannes Schneider-Thoma
    Irene Bighelli
    Adriani Nikolakopoulou
    Stefan Leucht
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 : 625 - 639
  • [20] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Krause, Marc
    Zhu, Yikang
    Huhn, Maximilian
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Nikolakopoulou, Adriani
    Leucht, Stefan
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (07) : 625 - 639
12345